183 related articles for article (PubMed ID: 32149760)
21. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
Feng C; Liu Y; Wang L; Niu D; Han B
Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
[TBL] [Abstract][Full Text] [Related]
22. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
Huang D; Qian J; Ge L; Jin X; Jin H; Ma J; Liu Z; Zhang F; Dong L; Wang X; Yao K; Ge J
Am Heart J; 2012 Sep; 164(3):394-401. PubMed ID: 22980307
[TBL] [Abstract][Full Text] [Related]
23. The use of intracoronary sodium nitroprusside to treat no-reflow after primary percutaneous coronary intervention in acute myocardial infarction.
Tesic MB; Stankovic G; Vukcevic V; Ostojic MC
Herz; 2010 Mar; 35(2):114-8. PubMed ID: 20376646
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for No-Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
Liang T; Liu M; Wu C; Zhang Q; Lu L; Wang Z
Rev Invest Clin; 2017; 69(3):139-145. PubMed ID: 28613283
[TBL] [Abstract][Full Text] [Related]
25. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction.
Sakata Y; Kodama K; Ishikura F; Komamura K; Hasegawa S; Sakata Y; Hirayama A
Jpn Circ J; 1997 May; 61(5):455-8. PubMed ID: 9192246
[TBL] [Abstract][Full Text] [Related]
26. [Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction].
Gan LJ; Zhang CH; Zhang M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):348-51. PubMed ID: 20669666
[TBL] [Abstract][Full Text] [Related]
27. Effect of intra-coronary nicorandil administration prior to reperfusion in acute ST segment elevation myocardial infarction.
Lee HC; An SG; Choi JH; Lee TK; Kim J; Kim JH; Chun KJ; Hong TJ; Shin YW; Lee SK
Circ J; 2008 Sep; 72(9):1425-9. PubMed ID: 18724016
[TBL] [Abstract][Full Text] [Related]
28. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
29. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.
Hillegass WB; Dean NA; Liao L; Rhinehart RG; Myers PR
J Am Coll Cardiol; 2001 Apr; 37(5):1335-43. PubMed ID: 11300444
[TBL] [Abstract][Full Text] [Related]
30. Intracoronary injection of drugs to treat no--reflow phenomenon and microcirculatory dysfunction.
Rognoni A; Lupi A; Cavallino C; Secco GG; Rosso R; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):84-8. PubMed ID: 22973862
[TBL] [Abstract][Full Text] [Related]
31. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
[TBL] [Abstract][Full Text] [Related]
32. Matrix Metalloproteinase-9 in the Culprit Coronary Artery and Myocardial No-Reflow.
Dong M; Mu N; Ren F; Li F; Zhang C; Yang J
Am J Med Sci; 2015 Nov; 350(5):352-6. PubMed ID: 26359995
[TBL] [Abstract][Full Text] [Related]
33. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
[TBL] [Abstract][Full Text] [Related]
34. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients.
Yang L; Mu L; Sun L; Qi F; Guo R
Minerva Cardioangiol; 2017 Apr; 65(2):111-118. PubMed ID: 27249789
[TBL] [Abstract][Full Text] [Related]
35. Selective intracoronary administration of nitroprusside before balloon dilatation prevents slow reflow during percutaneous coronary intervention in patients with acute myocardial infarction.
Shinozaki N; Ichinose H; Yahikozawa K; Shimada H; Hoshino K
Int Heart J; 2007 Jul; 48(4):423-33. PubMed ID: 17827814
[TBL] [Abstract][Full Text] [Related]
36. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
37. Cochrane Corner: is there a benefit of using intracoronary vasodilators in ST segment elevation myocardial infarction?
Meier P; Timmis A; Casas JP; Otto C
Heart; 2013 Oct; 99(19):1381-2. PubMed ID: 24009306
[No Abstract] [Full Text] [Related]
38. Myocardial 'no-reflow' prevention.
Magro M; Springeling T; van Geuns RJ; Zijlstra F
Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
[TBL] [Abstract][Full Text] [Related]
39. No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization.
Dall'Ara G; Testa L; Tumscitz C; Mattesini A; Gasparini GL; Grotti S; Bollati M; Tarantino F; Di Mario C; Oreglia JA
J Invasive Cardiol; 2020 Feb; 32(2):58-63. PubMed ID: 32005785
[TBL] [Abstract][Full Text] [Related]
40. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.
Morishima I; Sone T; Okumura K; Tsuboi H; Kondo J; Mukawa H; Matsui H; Toki Y; Ito T; Hayakawa T
J Am Coll Cardiol; 2000 Oct; 36(4):1202-9. PubMed ID: 11028471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
